—Contributing to the cost reduction of ongoing chiplet development— TOKYO–(BUSINESS WIRE)–Shin-Etsu Chemical Co., Ltd. (TOKYO: 4063)…
Categoría: Business Wire
Category Added in a WPeMatico Campaign
CRGE Investors Have Opportunity to Lead Charge Enterprises, Inc. Securities Fraud Lawsuit
NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of…
Queensland Residents in Australia Embrace Digital Driver Licences Powered and Protected by Thales
Since its launch in late 2023 by the Queensland Department of Transport and Main Roads (TMR),…
Tula Technology to Demonstrate Dynamic Motor Drive® (DMD) at SIA Powertrain 2024 International Congress
Tesla Model 3 Retrofitted with DMD and EESM Available for Test Drives SAN JOSE, Calif.–(BUSINESS WIRE)–#DMD—Tula…
Best’s Market Segment Report: AM Best Maintains Outlook on Italy’s Life Insurance Segment at Negative
AMSTERDAM–(BUSINESS WIRE)–#insurance—AM Best is maintaining its market segment outlook on Italy’s life insurance segment at negative.…
Best’s Market Segment Report: AM Best Revises Outlook on Italy’s Non-Life Insurance Segment to Stable
AMSTERDAM–(BUSINESS WIRE)–#insurance—AM Best is revising its market segment outlook on Italy’s non-life insurance segment to stable…
FDA Approves Almirall’s Klisyri® (tirbanibulin) for the Treatment of Actinic Keratosis on Expanded Area of Face or Scalp up to 100 cm2
Original FDA approval (December 2020) now extended to the use of Klisyri on larger areas of…
Milliman Opens Modelling Excellence Center in Madrid
Karol Maciejewski will lead as the Head of Life Modelling MADRID–(BUSINESS WIRE)–Milliman, Inc., a premier global…
Medincell Publishes Its Consolidated Annual Financial Results
(April 1st, 2023 – March 31st, 2024) MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Medincell (Paris:MEDCL): Highlights Commercial launch…
4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients
Lasare Phase I clinical trial demonstrated acceptable safety and tolerability profiles of 4P004 intra-articular liraglutide for…